Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Cricut
CRCT
$1.22B
| $289K | ﹤0.01% |
+47,100
| New | +$464K |
|
3477
VirTra
VTSI
$37.3M
| $289K | ﹤0.01% |
58,700
-29,100
| -33% | -$148K |
|
3478
Invesco S&P Global Water Index ETF
CGW
$1.06B
| $287K | ﹤0.01% |
6,500
-13,800
| -68% | -$658K |
|
|
CDAK
3479
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $287K | ﹤0.01% |
99,498
+80,998
| +438% | +$284K |
|
3480
iShares Intermediate Government/Credit Bond ETF
GVI
$3.8B
| $285K | ﹤0.01% |
+2,702
| New | +$287K |
|
3481
Scholar Rock
SRRK
$6.64B
| $285K | ﹤0.01% |
+51,900
| New | +$373K |
|
3482
INmune Bio
INMB
$58M
| $284K | ﹤0.01% |
+32,100
| New | +$239K |
|
3483
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$6.01B
| $284K | ﹤0.01% |
+12,000
| New | +$310K |
|
|
DLA
3484
DELISTED
Delta Apparel Inc.
DLA
| $283K | ﹤0.01% |
9,975
-9,525
| -49% | -$280K |
|
|
LABP
3485
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $283K | ﹤0.01% |
38,873
+4,823
| +14% | +$43.9K |
|
3486
Forte Biosciences
FBRX
$1.57B
| $282K | ﹤0.01% |
8,668
+1,092
| +14% | +$34.7K |
|
3487
Bankunited
BKU
$3.39B
| $281K | ﹤0.01% |
+7,900
| New | +$313K |
|
3488
iShares Core Dividend Growth ETF
DGRO
$43.8B
| $281K | ﹤0.01% |
+5,900
| New | +$297K |
|
|
AXIA.PR
3489
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $281K | ﹤0.01% |
39,906
+26,015
| +187% | +$174K |
|
3490
First Merchants
FRME
$2.73B
| $281K | ﹤0.01% |
+7,893
| New | +$311K |
|
3491
Greene County Bancorp
GCBC
$600M
| $281K | ﹤0.01% |
+12,400
| New | +$310K |
|
3492
StoneX
SNEX
$8.11B
| $281K | ﹤0.01% |
+18,225
| New | +$263K |
|
|
AUD
3493
DELISTED
Audacy, Inc.
AUD
| $281K | ﹤0.01% |
298,105
+194,705
| +188% | +$390K |
|
3494
Nuvation Bio
NUVB
$2.22B
| $280K | ﹤0.01% |
86,300
-5,900
| -6% | -$25.7K |
|
3495
Pyxis Tankers
PXS
$52.1M
| $280K | ﹤0.01% |
100,784
+25,184
| +33% | +$66.5K |
|
|
VIVS
3496
VivoSim Labs
VIVS
$1.15M
| $280K | ﹤0.01% |
13,174
-59
| -0.4% | -$1.84K |
|
3497
Daxor
DXR
$60.7M
| $279K | ﹤0.01% |
21,121
-1,300
| -6% | -$15.7K |
|
3498
Vanguard S&P 500 Value ETF
VOOV
$6.78B
| $279K | ﹤0.01% |
2,100
-1,100
| -34% | -$157K |
|
|
AMBR
3499
Amber International Holding Ltd
AMBR
$124M
| $279K | ﹤0.01% |
41,543
+35,873
| +633% | +$297K |
|
3500
Actinium Pharmaceuticals
ATNM
$28.9M
| $278K | ﹤0.01% |
+57,700
| New | +$328K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.